AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Dr. Reddy's Laboratories Ltd (RDY)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
AMNEAL PHARMACEUTICALS, INC. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $10.7B against $6.2B — 1.7× the size. Dr. Reddy's Laboratories Ltd trades at the lower P/E: 32.9× against 38.4×. AMNEAL PHARMACEUTICALS, INC. grew revenue faster over the last twelve months: 9.28% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs 5.05%) and the lower return on invested capital (5.89% vs 11.1%). Across the 21 metrics below, Dr. Reddy's Laboratories Ltd leads on 12 and AMNEAL PHARMACEUTICALS, INC. on 9.
Valuation
Profitability
| Metric | AMRX | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 50.00% | 53.94% |
| Operating margin | 14.56% | 10.91% | 0.00% |
| Net margin | 5.05% | 9.81% | 0.00% |
| Free cash flow margin | (0.37%) | 4.05% | 0.00% |
| Return on equity | (395.84%) | 8.21% | (0.40%) |
| Return on assets | 4.37% | 5.55% | (3.32%) |
| Return on invested capital | 11.05% | 5.89% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack